Structure

Physi-Chem Properties

Molecular Weight:  656.28
Volume:  658.808
LogP:  2.529
LogD:  2.189
LogS:  -4.423
# Rotatable Bonds:  12
TPSA:  171.96
# H-Bond Aceptor:  12
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.249
Synthetic Accessibility Score:  5.133
Fsp3:  0.571
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.419
MDCK Permeability:  0.00013739046698901802
Pgp-inhibitor:  0.996
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.693
20% Bioavailability (F20%):  0.288
30% Bioavailability (F30%):  0.979

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.335
Plasma Protein Binding (PPB):  52.076087951660156%
Volume Distribution (VD):  1.714
Pgp-substrate:  25.149198532104492%

ADMET: Metabolism

CYP1A2-inhibitor:  0.017
CYP1A2-substrate:  0.012
CYP2C19-inhibitor:  0.012
CYP2C19-substrate:  0.065
CYP2C9-inhibitor:  0.037
CYP2C9-substrate:  0.038
CYP2D6-inhibitor:  0.376
CYP2D6-substrate:  0.04
CYP3A4-inhibitor:  0.335
CYP3A4-substrate:  0.319

ADMET: Excretion

Clearance (CL):  3.408
Half-life (T1/2):  0.118

ADMET: Toxicity

hERG Blockers:  0.065
Human Hepatotoxicity (H-HT):  0.846
Drug-inuced Liver Injury (DILI):  0.93
AMES Toxicity:  0.066
Rat Oral Acute Toxicity:  0.843
Maximum Recommended Daily Dose:  0.908
Skin Sensitization:  0.109
Carcinogencity:  0.135
Eye Corrosion:  0.004
Eye Irritation:  0.018
Respiratory Toxicity:  0.984

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC162613

Natural Product ID:  NPC162613
Common Name*:   [(2S,4R,5R,5As,6S,8S,9Ar,10S,10As)-2,5,6,10-Tetraacetyloxy-8-Hydroxy-10A-(2-Hydroxypropan-2-Yl)-3,5A-Dimethyl-9-Methylidene-2,4,5,6,7,8,9A,10-Octahydro-1H-Benzo[G]Azulen-4-Yl] Benzoate
IUPAC Name:   [(2S,4R,5R,5aS,6S,8S,9aR,10S,10aS)-2,5,6,10-tetraacetyloxy-8-hydroxy-10a-(2-hydroxypropan-2-yl)-3,5a-dimethyl-9-methylidene-2,4,5,6,7,8,9a,10-octahydro-1H-benzo[g]azulen-4-yl] benzoate
Synonyms:  
Standard InCHIKey:  JQCUSGKZTBCFPV-BEISSDHJSA-N
Standard InCHI:  InChI=1S/C35H44O12/c1-17-24(40)15-26(44-20(4)37)34(9)28(17)30(45-21(5)38)35(33(7,8)42)16-25(43-19(3)36)18(2)27(35)29(31(34)46-22(6)39)47-32(41)23-13-11-10-12-14-23/h10-14,24-26,28-31,40,42H,1,15-16H2,2-9H3/t24-,25-,26-,28-,29+,30-,31-,34+,35-/m0/s1
SMILES:  C=C1[C@H](C[C@@H]([C@]2(C)[C@@H]1[C@@H]([C@@]1(C[C@@H](C(=C1[C@H]([C@@H]2OC(=O)C)OC(=O)c1ccccc1)C)OC(=O)C)C(C)(C)O)OC(=O)C)OC(=O)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL339718
PubChem CID:   5321678
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0000676] Taxanes and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31343 Taxus chinensis Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[12217376]
NPO31343 Taxus chinensis Species Taxaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO15125.1 Taxus wallichiana var. chinensis Varieties Taxaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO31343 Taxus chinensis Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO15125.1 Taxus wallichiana var. chinensis Varieties Taxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT137 Cell Line L1210 Mus musculus IC50 > 10.0 ug.mL-1 PMID[450072]
NPT2 Others Unspecified Control = 158.0 % PMID[450072]
NPT2 Others Unspecified Control = 313.0 % PMID[450072]
NPT27 Others Unspecified IC50 > 10.0 ug.mL-1 PMID[450072]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC162613 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC87934
0.9924 High Similarity NPC9905
0.985 High Similarity NPC192658
0.9704 High Similarity NPC34943
0.9632 High Similarity NPC125882
0.963 High Similarity NPC95449
0.9627 High Similarity NPC266374
0.9562 High Similarity NPC240115
0.9562 High Similarity NPC20255
0.9489 High Similarity NPC92867
0.9489 High Similarity NPC311825
0.9353 High Similarity NPC473760
0.9281 High Similarity NPC209592
0.9281 High Similarity NPC48599
0.9143 High Similarity NPC312393
0.9143 High Similarity NPC473602
0.9085 High Similarity NPC31829
0.9015 High Similarity NPC58061
0.8986 High Similarity NPC472547
0.8986 High Similarity NPC90614
0.8936 High Similarity NPC472556
0.8931 High Similarity NPC284022
0.8921 High Similarity NPC41481
0.8921 High Similarity NPC97947
0.8921 High Similarity NPC118080
0.8921 High Similarity NPC291599
0.8921 High Similarity NPC27377
0.8921 High Similarity NPC16912
0.8921 High Similarity NPC472576
0.8921 High Similarity NPC87448
0.8913 High Similarity NPC473301
0.8905 High Similarity NPC472372
0.8905 High Similarity NPC472374
0.8897 High Similarity NPC28836
0.8857 High Similarity NPC34012
0.8849 High Similarity NPC275592
0.8849 High Similarity NPC171207
0.8849 High Similarity NPC100913
0.8849 High Similarity NPC97667
0.8841 High Similarity NPC39549
0.8828 High Similarity NPC138641
0.8828 High Similarity NPC22571
0.8828 High Similarity NPC469648
0.8828 High Similarity NPC469647
0.8828 High Similarity NPC233581
0.8828 High Similarity NPC283875
0.8828 High Similarity NPC145649
0.8824 High Similarity NPC472248
0.8811 High Similarity NPC132652
0.8811 High Similarity NPC327031
0.8803 High Similarity NPC472575
0.8803 High Similarity NPC70403
0.8803 High Similarity NPC470159
0.8803 High Similarity NPC472568
0.8803 High Similarity NPC469349
0.8803 High Similarity NPC471104
0.8803 High Similarity NPC29704
0.8803 High Similarity NPC174982
0.8803 High Similarity NPC177940
0.8803 High Similarity NPC472572
0.8803 High Similarity NPC473088
0.8803 High Similarity NPC184817
0.8803 High Similarity NPC96903
0.8803 High Similarity NPC171525
0.8803 High Similarity NPC476973
0.8803 High Similarity NPC472571
0.8803 High Similarity NPC470157
0.8803 High Similarity NPC158663
0.8803 High Similarity NPC200471
0.8794 High Similarity NPC163087
0.8794 High Similarity NPC131966
0.8794 High Similarity NPC191387
0.8794 High Similarity NPC477894
0.8786 High Similarity NPC242355
0.8768 High Similarity NPC472551
0.8768 High Similarity NPC472545
0.8768 High Similarity NPC202729
0.8759 High Similarity NPC311492
0.875 High Similarity NPC239358
0.875 High Similarity NPC233692
0.875 High Similarity NPC233860
0.8741 High Similarity NPC478263
0.8732 High Similarity NPC470152
0.8732 High Similarity NPC70716
0.8732 High Similarity NPC241951
0.8732 High Similarity NPC95265
0.8732 High Similarity NPC125106
0.8732 High Similarity NPC95810
0.8732 High Similarity NPC57628
0.8732 High Similarity NPC472573
0.8732 High Similarity NPC25768
0.8732 High Similarity NPC476974
0.8732 High Similarity NPC38696
0.8732 High Similarity NPC472569
0.8732 High Similarity NPC188865
0.8732 High Similarity NPC472570
0.8732 High Similarity NPC475122
0.8732 High Similarity NPC475759
0.8732 High Similarity NPC11685
0.8732 High Similarity NPC163719
0.8723 High Similarity NPC472546
0.8707 High Similarity NPC132599
0.8707 High Similarity NPC473611
0.8707 High Similarity NPC469730
0.8707 High Similarity NPC473632
0.8705 High Similarity NPC27721
0.8696 High Similarity NPC200154
0.8696 High Similarity NPC291638
0.8696 High Similarity NPC472577
0.8696 High Similarity NPC195647
0.8696 High Similarity NPC477893
0.8696 High Similarity NPC66761
0.8696 High Similarity NPC17877
0.869 High Similarity NPC476173
0.8671 High Similarity NPC478264
0.8671 High Similarity NPC25043
0.8671 High Similarity NPC134131
0.8662 High Similarity NPC91703
0.8652 High Similarity NPC224491
0.8649 High Similarity NPC11410
0.8639 High Similarity NPC471135
0.863 High Similarity NPC470153
0.863 High Similarity NPC472398
0.8623 High Similarity NPC298547
0.8623 High Similarity NPC134937
0.8623 High Similarity NPC474608
0.8623 High Similarity NPC324898
0.8621 High Similarity NPC301556
0.8621 High Similarity NPC92293
0.8621 High Similarity NPC270590
0.8621 High Similarity NPC471101
0.8621 High Similarity NPC476975
0.8621 High Similarity NPC76103
0.8621 High Similarity NPC266265
0.8611 High Similarity NPC474935
0.8603 High Similarity NPC147561
0.8592 High Similarity NPC140021
0.8582 High Similarity NPC184747
0.8582 High Similarity NPC4341
0.8582 High Similarity NPC473085
0.8582 High Similarity NPC473081
0.8582 High Similarity NPC473613
0.8582 High Similarity NPC48017
0.8582 High Similarity NPC200592
0.8582 High Similarity NPC147880
0.8582 High Similarity NPC43241
0.8582 High Similarity NPC473758
0.8582 High Similarity NPC211137
0.8582 High Similarity NPC473109
0.8582 High Similarity NPC473112
0.8582 High Similarity NPC473060
0.8582 High Similarity NPC476094
0.8582 High Similarity NPC275576
0.8581 High Similarity NPC251139
0.8571 High Similarity NPC327511
0.8571 High Similarity NPC205305
0.8562 High Similarity NPC473214
0.8562 High Similarity NPC125033
0.8562 High Similarity NPC470245
0.8561 High Similarity NPC477896
0.8561 High Similarity NPC149401
0.8561 High Similarity NPC279637
0.8552 High Similarity NPC281717
0.8533 High Similarity NPC319404
0.8523 High Similarity NPC475548
0.8523 High Similarity NPC290683
0.8523 High Similarity NPC475638
0.8519 High Similarity NPC169913
0.8511 High Similarity NPC53361
0.8511 High Similarity NPC210591
0.8511 High Similarity NPC475652
0.8511 High Similarity NPC121268
0.8511 High Similarity NPC214550
0.8503 High Similarity NPC96308
0.8493 Intermediate Similarity NPC473215
0.8489 Intermediate Similarity NPC48929
0.8489 Intermediate Similarity NPC153617
0.8478 Intermediate Similarity NPC238370
0.8467 Intermediate Similarity NPC475508
0.8467 Intermediate Similarity NPC318447
0.8467 Intermediate Similarity NPC322048
0.8462 Intermediate Similarity NPC182869
0.8456 Intermediate Similarity NPC21410
0.8456 Intermediate Similarity NPC473670
0.8451 Intermediate Similarity NPC183270
0.8451 Intermediate Similarity NPC477904
0.8446 Intermediate Similarity NPC477905
0.8446 Intermediate Similarity NPC472548
0.844 Intermediate Similarity NPC183122
0.844 Intermediate Similarity NPC475373
0.844 Intermediate Similarity NPC283375
0.8435 Intermediate Similarity NPC7095
0.8425 Intermediate Similarity NPC217918
0.8421 Intermediate Similarity NPC476077
0.8414 Intermediate Similarity NPC127857
0.8411 Intermediate Similarity NPC476784
0.8406 Intermediate Similarity NPC72915
0.8403 Intermediate Similarity NPC191082
0.8403 Intermediate Similarity NPC475429
0.8403 Intermediate Similarity NPC473673

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC162613 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8041 Intermediate Similarity NPD7236 Approved
0.7895 Intermediate Similarity NPD7239 Suspended
0.7857 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7799 Discontinued
0.7692 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7591 Intermediate Similarity NPD7741 Discontinued
0.7556 Intermediate Similarity NPD2629 Approved
0.755 Intermediate Similarity NPD4628 Phase 3
0.7515 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD7057 Phase 3
0.7438 Intermediate Similarity NPD7058 Phase 2
0.7415 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7388 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD8368 Discontinued
0.7368 Intermediate Similarity NPD8434 Phase 2
0.7353 Intermediate Similarity NPD8407 Phase 2
0.7279 Intermediate Similarity NPD3764 Approved
0.7256 Intermediate Similarity NPD8127 Discontinued
0.7239 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD2182 Approved
0.7211 Intermediate Similarity NPD7008 Discontinued
0.7197 Intermediate Similarity NPD6273 Approved
0.7184 Intermediate Similarity NPD8361 Approved
0.7184 Intermediate Similarity NPD8360 Approved
0.7122 Intermediate Similarity NPD4198 Discontinued
0.7121 Intermediate Similarity NPD6647 Phase 2
0.7114 Intermediate Similarity NPD7961 Discontinued
0.711 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD7819 Suspended
0.709 Intermediate Similarity NPD6685 Approved
0.7086 Intermediate Similarity NPD8435 Approved
0.7076 Intermediate Similarity NPD7685 Pre-registration
0.7069 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD6190 Approved
0.7051 Intermediate Similarity NPD7274 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD690 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD5951 Approved
0.7013 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD6004 Phase 3
0.7013 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD6005 Phase 3
0.7013 Intermediate Similarity NPD6002 Phase 3
0.7 Intermediate Similarity NPD6663 Approved
0.6994 Remote Similarity NPD5761 Phase 2
0.6994 Remote Similarity NPD5760 Phase 2
0.6987 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6987 Remote Similarity NPD8166 Discontinued
0.6972 Remote Similarity NPD9545 Approved
0.697 Remote Similarity NPD7075 Discontinued
0.6959 Remote Similarity NPD5736 Approved
0.6944 Remote Similarity NPD8485 Approved
0.6944 Remote Similarity NPD7457 Clinical (unspecified phase)
0.694 Remote Similarity NPD164 Approved
0.6933 Remote Similarity NPD37 Approved
0.6918 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6914 Remote Similarity NPD6599 Discontinued
0.6914 Remote Similarity NPD4380 Phase 2
0.6909 Remote Similarity NPD4967 Phase 2
0.6909 Remote Similarity NPD4965 Approved
0.6909 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6909 Remote Similarity NPD4966 Approved
0.6908 Remote Similarity NPD230 Phase 1
0.6908 Remote Similarity NPD6355 Discontinued
0.6903 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6901 Remote Similarity NPD5844 Phase 1
0.6897 Remote Similarity NPD6287 Discontinued
0.6894 Remote Similarity NPD1238 Approved
0.6892 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6892 Remote Similarity NPD6085 Phase 2
0.689 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6879 Remote Similarity NPD6765 Approved
0.6879 Remote Similarity NPD6764 Approved
0.6879 Remote Similarity NPD3750 Approved
0.6875 Remote Similarity NPD5126 Approved
0.6875 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6875 Remote Similarity NPD8150 Discontinued
0.6875 Remote Similarity NPD5125 Phase 3
0.6866 Remote Similarity NPD5738 Clinical (unspecified phase)
0.6866 Remote Similarity NPD5765 Approved
0.6863 Remote Similarity NPD6653 Approved
0.6859 Remote Similarity NPD970 Clinical (unspecified phase)
0.6852 Remote Similarity NPD7458 Discontinued
0.6852 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6848 Remote Similarity NPD5402 Approved
0.6839 Remote Similarity NPD2935 Discontinued
0.6835 Remote Similarity NPD6912 Phase 3
0.6832 Remote Similarity NPD5403 Approved
0.6831 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6829 Remote Similarity NPD6801 Discontinued
0.6816 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6815 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6815 Remote Similarity NPD1237 Approved
0.6813 Remote Similarity NPD2533 Approved
0.6813 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6813 Remote Similarity NPD2532 Approved
0.6813 Remote Similarity NPD2534 Approved
0.6812 Remote Similarity NPD2067 Discontinued
0.6807 Remote Similarity NPD7768 Phase 2
0.68 Remote Similarity NPD8312 Approved
0.68 Remote Similarity NPD8313 Approved
0.6795 Remote Similarity NPD5763 Approved
0.6795 Remote Similarity NPD5762 Approved
0.6795 Remote Similarity NPD7266 Discontinued
0.6786 Remote Similarity NPD7094 Approved
0.6786 Remote Similarity NPD6858 Approved
0.6784 Remote Similarity NPD7473 Discontinued
0.6781 Remote Similarity NPD4806 Approved
0.6781 Remote Similarity NPD4807 Approved
0.6774 Remote Similarity NPD2799 Discontinued
0.6774 Remote Similarity NPD7305 Phase 1
0.6772 Remote Similarity NPD7003 Approved
0.6772 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6766 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6765 Remote Similarity NPD5048 Discontinued
0.6763 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6759 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6759 Remote Similarity NPD5305 Approved
0.6759 Remote Similarity NPD5306 Approved
0.675 Remote Similarity NPD6799 Approved
0.6748 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6747 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6741 Remote Similarity NPD1930 Approved
0.6741 Remote Similarity NPD1929 Approved
0.6741 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6731 Remote Similarity NPD7137 Phase 2
0.6726 Remote Similarity NPD6234 Discontinued
0.6724 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6723 Remote Similarity NPD6784 Approved
0.6723 Remote Similarity NPD6785 Approved
0.6711 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6708 Remote Similarity NPD5401 Approved
0.6706 Remote Similarity NPD6232 Discontinued
0.6691 Remote Similarity NPD5909 Discontinued
0.6689 Remote Similarity NPD6832 Phase 2
0.6688 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6687 Remote Similarity NPD8455 Phase 2
0.6686 Remote Similarity NPD6559 Discontinued
0.6667 Remote Similarity NPD3748 Approved
0.6667 Remote Similarity NPD7411 Suspended
0.6667 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7033 Discontinued
0.6667 Remote Similarity NPD7714 Approved
0.6667 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7715 Approved
0.6667 Remote Similarity NPD7610 Discontinued
0.6667 Remote Similarity NPD4110 Phase 3
0.6647 Remote Similarity NPD7228 Approved
0.6647 Remote Similarity NPD3817 Phase 2
0.6647 Remote Similarity NPD7199 Phase 2
0.6647 Remote Similarity NPD3818 Discontinued
0.6646 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6646 Remote Similarity NPD3226 Approved
0.6645 Remote Similarity NPD3528 Clinical (unspecified phase)
0.6642 Remote Similarity NPD2066 Phase 3
0.6631 Remote Similarity NPD7497 Discontinued
0.6627 Remote Similarity NPD1934 Approved
0.6626 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6624 Remote Similarity NPD2438 Suspended
0.6624 Remote Similarity NPD6099 Approved
0.6624 Remote Similarity NPD6100 Approved
0.6624 Remote Similarity NPD1551 Phase 2
0.6623 Remote Similarity NPD4140 Approved
0.6622 Remote Similarity NPD1608 Approved
0.6609 Remote Similarity NPD7804 Clinical (unspecified phase)
0.66 Remote Similarity NPD2797 Approved
0.6599 Remote Similarity NPD4135 Approved
0.6599 Remote Similarity NPD4136 Approved
0.6599 Remote Similarity NPD4106 Approved
0.6597 Remote Similarity NPD9493 Approved
0.6587 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6582 Remote Similarity NPD2346 Discontinued
0.6571 Remote Similarity NPD7074 Phase 3
0.6567 Remote Similarity NPD9495 Approved
0.6562 Remote Similarity NPD2575 Approved
0.6561 Remote Similarity NPD4308 Phase 3
0.6561 Remote Similarity NPD1510 Phase 2
0.6558 Remote Similarity NPD8032 Phase 2
0.6556 Remote Similarity NPD5647 Approved
0.6541 Remote Similarity NPD1549 Phase 2
0.6536 Remote Similarity NPD7095 Approved
0.6533 Remote Similarity NPD1876 Approved
0.6532 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6532 Remote Similarity NPD6166 Phase 2
0.6532 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6532 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6529 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6519 Remote Similarity NPD5405 Approved
0.6519 Remote Similarity NPD2796 Approved
0.6519 Remote Similarity NPD5408 Approved
0.6519 Remote Similarity NPD7798 Approved
0.6519 Remote Similarity NPD5404 Approved
0.6519 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6519 Remote Similarity NPD5406 Approved
0.6516 Remote Similarity NPD1240 Approved
0.6514 Remote Similarity NPD7054 Approved
0.6513 Remote Similarity NPD5204 Approved
0.651 Remote Similarity NPD6637 Approved
0.6509 Remote Similarity NPD3882 Suspended
0.6508 Remote Similarity NPD8320 Phase 1
0.6508 Remote Similarity NPD8319 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data